Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation
Clinical trial NCT02614872 · COMPLETED
Trial details
- NCT number
- NCT02614872
- Sponsor
- Kamada, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-26
- Primary completion
- 2019-04-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.